Twist Bioscience Corporation growth

Reported trailing growth, forward expectations and three-year compound growth rates.

Trailing growth

Year over year

Revenue: +17.8%
EBITDA: +65.4%
EBIT: +31.0%
EPS: +59.5%
Free cash flow: -45.3%
Operating cash flow: +0.9%

Forward estimates

Revenue: +19.2%
EBITDA: —
EPS: +4.6%

Three-year CAGR

Revenue: +22.8%
EBITDA: +70.5%
EBIT: +38.3%
Net income: +62.8%
EPS: +63.9%
Free cash flow: -9.3%

Latest available reported and market-derived figures. A dash means the source dataset does not currently cover that metric; it does not imply a zero value.